All Stories

  1. Cancer risk in severe alpha-1-antitrypsin deficiency
  2. Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
  3. Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency